In addition to the CCK-8 assay confirming alterations in proliferative capacity, EdU assays further validated TTC26’s functional role in tumor cells: TTC26 overexpression significantly enhanced proliferative activity, while the knockout group displayed markedly reduced proliferation (Figures 8H, I). Here, IFT56 is linked to neoplasm.